Showing results (101-110 of 147) with videos related to

Sort By:
Pageof 15
The Journal of Molecular Diagnostics : JMD|February 8, 2019
Genomic Analysis of Circulating Tumor DNA Using a Melanoma-Specific UltraSEEK Oncogene PanelElin S Gray, Tom Witkowski, Michelle Pereira, et al.
Molecular Oncology|October 13, 2018
Locus-specific concordance of genomic alterations between tissue and plasma circulating tumor DNA in metastatic melanomaLeslie Calapre, Tindaro Giardina, Cleo Robinson, et al.
Cancers|December 19, 2020
The Prognostic Impact of Circulating Tumour DNA in Melanoma Patients Treated with Systemic Therapies-Beyond BRAF Mutant DetectionGabriela Marsavela, Peter A Johansson, Michelle R Pereira, et al.
Oncotarget|November 20, 2020
Detection of BRAF splicing variants in plasma-derived cell-free nucleic acids and extracellular vesicles of melanoma patients failing targeted therapy therapiesMichael E Clark, Helen Rizos, Michelle R Pereira, et al.
Translational Vision Science & Technology|November 19, 2019
A Panel of Circulating MicroRNAs Detects Uveal Melanoma With High PrecisionMitchell S Stark, Elin S Gray, Timothy Isaacs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2021
Phase I/IIa Trial of BMS-986148, an Anti-mesothelin Antibody-drug Conjugate, Alone or in Combination with Nivolumab in Patients with Advanced Solid TumorsSylvie Rottey, Jeffrey Clarke, Kyaw Aung, et al.
European Journal of Cancer (Oxford, England : 1990)|December 22, 2019
Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy: Analysis from phase 2 and 3 clinical trialsAxel Hauschild, Paolo A Ascierto, Dirk Schadendorf, et al.
The Oncologist|June 16, 2021
A Phase I, First-in-Human Study of GSK2849330, an Anti-HER3 Monoclonal Antibody, in HER3-Expressing Solid TumorsHui K Gan, Michael Millward, Mathilde Jalving, et al.
Drug Design, Development and Therapy|April 8, 2020
A First-in-Human Dose Finding Study of Camrelizumab in Patients with Advanced or Metastatic Cancer in AustraliaJason D Lickliter, Hui K Gan, Mark Voskoboynik, et al.
Investigational New Drugs|November 15, 2011
Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combinationMichael Millward, Timothy Price, Amanda Townsend, et al.
Pageof 15